ROSWELL, Ga., Dec. 10, 2018 /PRNewswire/ -- StimLabs, LLC, a leader in regenerative technologies and products that are revolutionizing patient care, is pleased to announce availability of all StimLabs products through both the Federal Supply Schedule (FSS) and Distribution and Pricing Agreement (DAPA). Through a continued partnership with the American Military Medical Organization, LLC (AMMO), both Revita and Ascent products are now much more accessible at both the Department of Veterans Affairs (VA) and the Department of Defense (DoD).
"These FSS and DAPA listings make it easier than ever for active-duty military and veterans to access the complete portfolio of StimLabs products," said John Daniel, Founder and CEO of StimLabs. "Our Revita and Ascent products have set a new standard in the amniotic tissue market, and we're excited to bring them to even more military service members."
About StimLabs
StimLabs, LLC, was founded in 2015 with a desire to advance the state of regenerative medicine. Within a year of its inception, StimLabs built and certified an ISO Class 7 clean room facility, conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. StimLabs portfolio of products includes Ascent™, a shelf-stable injectable amniotic fluid allograft, and Revita®, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format. These groundbreaking products apply to a wide range of clinical applications and provide a foundation on which StimLabs is developing new regenerative technologies at the intersection of pharmaceuticals, medical devices, and tissue transplants. For more information, visit www.stimlabs.com.
About AMMO
The American Military Medical Organization is a Center for Veterans Enterprise (CVE) verified VOSB. Their mission is to provide the highest quality and most cost effective medical devices and supplies to healthcare providers. For more information, visit www.ammomedicalsupply.com.
ContactChas Harris1225 Northmeadow Parkway Suite 104Roswell, GA [email protected] www.stimlabs.com
Advertisement
"These FSS and DAPA listings make it easier than ever for active-duty military and veterans to access the complete portfolio of StimLabs products," said John Daniel, Founder and CEO of StimLabs. "Our Revita and Ascent products have set a new standard in the amniotic tissue market, and we're excited to bring them to even more military service members."
Advertisement
About StimLabs
StimLabs, LLC, was founded in 2015 with a desire to advance the state of regenerative medicine. Within a year of its inception, StimLabs built and certified an ISO Class 7 clean room facility, conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. StimLabs portfolio of products includes Ascent™, a shelf-stable injectable amniotic fluid allograft, and Revita®, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format. These groundbreaking products apply to a wide range of clinical applications and provide a foundation on which StimLabs is developing new regenerative technologies at the intersection of pharmaceuticals, medical devices, and tissue transplants. For more information, visit www.stimlabs.com.
About AMMO
The American Military Medical Organization is a Center for Veterans Enterprise (CVE) verified VOSB. Their mission is to provide the highest quality and most cost effective medical devices and supplies to healthcare providers. For more information, visit www.ammomedicalsupply.com.
ContactChas Harris1225 Northmeadow Parkway Suite 104Roswell, GA [email protected] www.stimlabs.com
View original content:http://www.prnewswire.com/news-releases/stimlabs-announces-department-of-veterans-affairs-va-and-department-of-defense-dod-agreements-300762535.html
SOURCE StimLabs
